APA (7th ed.) Citation

GH, K., T, R., P, P., KT, D., AC, G., WV, M., . . . MA, C. (2009). Design, synthesis, and biological evaluation of (2R,alphaS)-3,4-dihydro-2-[3-(1,1,2,2-tetrafluoroethoxy)phenyl]-5-[3-(trifluoromethoxy)-phenyl]-alpha-(trifluoromethyl)-1(2H)-quinolineethanol as potent and orally active cholesteryl ester transfer protein inhibitor. Journal of medicinal chemistry, 52(6), 1768. https://doi.org/10.1021/jm801319d

Chicago Style (17th ed.) Citation

GH, Kuo, Rano T, Pelton P, Demarest KT, Gibbs AC, Murray WV, Damiano BP, and Connelly MA. "Design, Synthesis, and Biological Evaluation of (2R,alphaS)-3,4-dihydro-2-[3-(1,1,2,2-tetrafluoroethoxy)phenyl]-5-[3-(trifluoromethoxy)-phenyl]-alpha-(trifluoromethyl)-1(2H)-quinolineethanol as Potent and Orally Active Cholesteryl Ester Transfer Protein Inhibitor." Journal of Medicinal Chemistry 52, no. 6 (2009): 1768. https://doi.org/10.1021/jm801319d.

MLA (9th ed.) Citation

GH, Kuo, et al. "Design, Synthesis, and Biological Evaluation of (2R,alphaS)-3,4-dihydro-2-[3-(1,1,2,2-tetrafluoroethoxy)phenyl]-5-[3-(trifluoromethoxy)-phenyl]-alpha-(trifluoromethyl)-1(2H)-quinolineethanol as Potent and Orally Active Cholesteryl Ester Transfer Protein Inhibitor." Journal of Medicinal Chemistry, vol. 52, no. 6, 2009, p. 1768, https://doi.org/10.1021/jm801319d.